Joel Morganroth & Ihor Gussak 
Cardiac Safety of Noncardiac Drugs [PDF ebook] 
Practical Guidelines for Clinical Research and Drug Development

Ondersteuning
€149.79
Betalingsmethoden

Inhoudsopgave

Cardiac Safety of Noncardiac Drugs.- Preclinical and Pharmacogenomic Cardiac Safety Evaluations.- Molecular Physiology of Ion Channels That Control Cardiac Repolarization.- Cellular, Molecular, and Pharmacologic Mechanisms Underlying Drug-Induced Cardiac Arrhythmogenesis.- h ERG Assay, QT Liability, and Sudden Cardiac Death.- Pharmacogenomics in Drug Development.- Clinical Methodologies and Technical Aspects of Assessing Cardiac Safety of Investigational Drugs: Focus on Cardiac Repolarization.- Assessment of Ventricular Repolarization From Body-Surface ECGs in Humans.- ECG Acquisition and Signal Processing.- Digital 12-Lead Holter vs Standard Resting Supine Electrocardiogram for the Assessment of Drug-Induced QTc Prolongation.- Holter Monitoring for QT.- Application of ELectrocardiology in Clinical Research.- Fundamentals of ECG Interpretation in Clinical Research and Cardiac Safety Assessment.- Design and Conduct of the Thorough Phase I ECG Trial for New Bioactive Drugs.- Use of ECGs in Support of Cardiac Safety in Phase II and III Clinical Trials.- Cardiac Arrhythmia Assessment in Phase IV Clinical Studies.- Statistical Analysis Plans for ECG Data.- Interpretation of Clinical ECG Data.- Regulatory COnsiderations.- The FDA’s Digital ECG Initiative and Its Impact on Clinical Trials.- Quality Control and Quality Assurance for Core ECG Laboratories.- ECG Digital Communities and Electronic Reporting of Cardiac Safety Data.

Koop dit e-boek en ontvang er nog 1 GRATIS!
Taal Engels ● Formaat PDF ● Pagina’s 362 ● ISBN 9781592598847 ● Bestandsgrootte 7.8 MB ● Editor Joel Morganroth & Ihor Gussak ● Uitgeverij Humana Press ● Stad NJ ● Land US ● Gepubliceerd 2007 ● Downloadbare 24 maanden ● Valuta EUR ● ID 2150660 ● Kopieerbeveiliging Sociale DRM

Meer e-boeken van dezelfde auteur (s) / Editor

763 E-boeken in deze categorie